TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in OmicInsight Corporation ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...

SANTA CLARA, MD, UNITED STATES, January 5, 2026 /EINPresswire.com/ — OmicInsight Corporation (hereinafter “OmicInsight”), a pioneer in AI-driven high-sensitivity spatial omics analysis, today ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University Chobanian & Avedisian School of Medicine, have developed a software platform to ...

This illustration summarizes how integrated spatial transcriptomics, single-cell transcriptomics, single-cell epigenomics, and spatial epigenomics enable multi-dimensional profiling of the tumor ...

Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures ...

In this collection we highlight a wide range of spatial imaging and spatial omics approaches that enable the spatial visualization of molecular targets in biological tissue. The protocols span between ...

Functional classification of tumor biomarkers by molecular type and clinical applications. Tumor biomarkers are categorized into genetic, protein, epigenetic, and metabolic types, each associated with ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University School of Medicine have developed software to help scientists more easily analyze ...

ST. LOUIS--(BUSINESS WIRE)--Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape TM system, the next generation in ChipCytometry TM instrumentation, advancing ...